210 related articles for article (PubMed ID: 8964395)
1. Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis.
Löfberg R; Danielsson A; Suhr O; Nilsson A; Schiöler R; Nyberg A; Hultcrantz R; Kollberg B; Gillberg R; Willén R; Persson T; Salde L
Gastroenterology; 1996 Jun; 110(6):1713-8. PubMed ID: 8964395
[TBL] [Abstract][Full Text] [Related]
2. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis.
Löfberg R; Ostergaard Thomsen O; Langholz E; Schiöler R; Danielsson A; Suhr O; Graffner H; Påhlman L; Matzen P; Møller-Petersen JF
Aliment Pharmacol Ther; 1994 Dec; 8(6):623-9. PubMed ID: 7696452
[TBL] [Abstract][Full Text] [Related]
3. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.
Campieri M; Ferguson A; Doe W; Persson T; Nilsson LG
Gut; 1997 Aug; 41(2):209-14. PubMed ID: 9301500
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis.
D'Haens GR; Kovács A; Vergauwe P; Nagy F; Molnár T; Bouhnik Y; Weiss W; Brunner H; Lavergne-Slove A; Binelli D; Di Stefano AF; Marteau P
J Crohns Colitis; 2010 Jun; 4(2):153-60. PubMed ID: 21122499
[TBL] [Abstract][Full Text] [Related]
5. A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis.
Danielsson A; Hellers G; Lyrenäs E; Löfberg R; Nilsson A; Olsson O; Olsson SA; Persson T; Salde L; Naesdal J
Scand J Gastroenterol; 1987 Oct; 22(8):987-92. PubMed ID: 3317784
[TBL] [Abstract][Full Text] [Related]
6. A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis.
Danielsson A; Löfberg R; Persson T; Salde L; Schiöler R; Suhr O; Willén R
Scand J Gastroenterol; 1992; 27(1):9-12. PubMed ID: 1736348
[TBL] [Abstract][Full Text] [Related]
7. Budesonide enema in distal ulcerative colitis. A randomized dose-response trial with prednisolone enema as positive control. The Danish Budesonide Study Group.
Scand J Gastroenterol; 1991 Dec; 26(12):1225-30. PubMed ID: 1763292
[TBL] [Abstract][Full Text] [Related]
8. Oral budesonide for induction of remission in ulcerative colitis.
Sherlock ME; Seow CH; Steinhart AH; Griffiths AM
Cochrane Database Syst Rev; 2010 Oct; (10):CD007698. PubMed ID: 20927762
[TBL] [Abstract][Full Text] [Related]
9. A comparison of budesonide with prednisolone for active Crohn's disease.
Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
[TBL] [Abstract][Full Text] [Related]
10. Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease.
Spencer CM; McTavish D
Drugs; 1995 Nov; 50(5):854-72. PubMed ID: 8586030
[TBL] [Abstract][Full Text] [Related]
11. Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial.
Escher JC;
Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):47-54. PubMed ID: 15095852
[TBL] [Abstract][Full Text] [Related]
12. Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis.
Naganuma M; Aoyama N; Suzuki Y; Nishino H; Kobayashi K; Hirai F; Watanabe K; Hibi T
J Crohns Colitis; 2016 Jul; 10(7):828-36. PubMed ID: 26577683
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of budesonide enema in patients with distal ulcerative colitis or proctitis.
Danielsson A; Edsbäcker S; Löfberg R; Nilsson A; Nyman-Pantelidis M; Olsson O; Suhr O; Willén R
Aliment Pharmacol Ther; 1993 Aug; 7(4):401-7. PubMed ID: 8218754
[TBL] [Abstract][Full Text] [Related]
14. Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis.
Lichtenstein GR; Travis S; Danese S; D'Haens G; Moro L; Jones R; Huang M; Ballard ED; Bagin R; Hardiman Y; Collazo R; Sandborn WJ
J Crohns Colitis; 2015 Sep; 9(9):738-46. PubMed ID: 26094251
[TBL] [Abstract][Full Text] [Related]
15. Budesonide with multi-matrix technology as second-line treatment for ulcerative colitis: evaluation of long-term cost-effectiveness in the Netherlands.
Gherardi A; Roze S; Kuijvenhoven J; Ghatnekar O; Yip Sonderegger YL
J Med Econ; 2018 Sep; 21(9):869-877. PubMed ID: 29857775
[TBL] [Abstract][Full Text] [Related]
16. Oral budesonide therapy for steroid-dependent ulcerative colitis: a pilot trial.
Keller R; Stoll R; Foerster EC; Gutsche N; Domschke W
Aliment Pharmacol Ther; 1997 Dec; 11(6):1047-52. PubMed ID: 9663828
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of oral budesonide in the treatment of active distal ulcerative colitis.
Kolkman JJ; Möllmann HW; Möllmann AC; Penã AS; Greinwald R; Tauschel HD; Hochhaus G
Drugs Today (Barc); 2004 Jul; 40(7):589-601. PubMed ID: 15510233
[TBL] [Abstract][Full Text] [Related]
18. Budesonide in inflammatory bowel disease.
Lamers CB; Wagtmans MJ; van der Sluys Veer A; van Hogezand RA; Griffioen G
Neth J Med; 1996 Feb; 48(2):60-3. PubMed ID: 8819801
[TBL] [Abstract][Full Text] [Related]
19. Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis.
Lémann M; Galian A; Rutgeerts P; Van Heuverzwijn R; Cortot A; Viteau JM; Elewaut A; Belaiche J; Froguel E; Modigliani R
Aliment Pharmacol Ther; 1995 Oct; 9(5):557-62. PubMed ID: 8580278
[TBL] [Abstract][Full Text] [Related]
20. Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study.
Naganuma M; Aoyama N; Tada T; Kobayashi K; Hirai F; Watanabe K; Watanabe M; Hibi T
J Gastroenterol; 2018 Apr; 53(4):494-506. PubMed ID: 28779419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
